Business Momentum Will Accelerate As International Headwinds Ease And Markets Stabilize

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

14 Sep 24

Updated

07 Dec 25

Views

118

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

-35.8%

7D

-0.5%

Loading

1Y

-35.8%

7D

-0.5%

You can edit this narrative until Dec 8 12:10 AM. Then, changes will post as Updates.

Author's Valuation

US$7.1447.5% undervalued

AnalystConsensusTarget Fair Value

Shared on 07 Dec 25

Fair value Decreased 1.38%

VTEX: Cost Discipline And Share Repurchases Will Drive Future Free Cash Flow

Analysts have nudged their fair value estimate for VTEX slightly lower, trimming the target from $7.24 to $7.14 per share. They are balancing more cautious growth and discount rate assumptions against supportive Street research highlighting improving margins, healthier free cash flow prospects, and an increasingly attractive valuation after the recent selloff.

Shared on 22 Nov 25

Fair value Increased 1.19%

VTEX: Cost Controls And Market Resilience Will Drive Free Cash Flow Recovery

VTEX’s analyst fair value price target has increased slightly from $7.15 to $7.24. Analysts cite improved profit margin forecasts and resilience in medium-term growth expectations as the primary drivers for the upward revision.

Shared on 07 Nov 25

VTEX: Cost Discipline And AI Solutions Will Drive Free Cash Flow Upside

Analysts have adjusted their price targets for VTEX, with Jefferies lowering its target from $7.30 to $6.50. Recent research cites concerns about near-term growth but also highlights a view that the stock remains undervalued after its sharp decline.

Shared on 23 Oct 25

Fair value Decreased 5.86%

Analysts have lowered their fair value price target for VTEX to $7.15 from $7.60 per share, citing a softer growth outlook and recent valuation adjustments. This follows mixed research sentiment and recent updates to company guidance.

Shared on 09 Oct 25

Fair value Decreased 7.32%

Analysts have lowered their price target for VTEX, reducing the fair value estimate from $8.20 to $7.60 due to concerns over slower growth. This adjustment is partially offset by improvements in profit margin and overall valuation following a recent market selloff.

Shared on 22 Aug 25

Fair value Decreased 7.52%

Analysts have reduced their price target for VTEX from $8.87 to $8.42 amid weaker-than-expected Q2 growth, ongoing macroeconomic headwinds in key Latin American markets, and lowered 2025 guidance, which has increased near-term caution despite continued confidence in long-term sector drivers. Analyst Commentary Weak growth in Q2, especially due to deteriorating conditions in Argentina and Brazil, prompting reduced growth outlook.

Shared on 01 May 25

Fair value Decreased 0.93%

Shared on 23 Apr 25

Fair value Decreased 0.56%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Fair value Decreased 4.46%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Increased 1.78%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Decreased 0.58%

Shared on 26 Mar 25

Fair value Decreased 1.79%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Increased 7.24%

AnalystConsensusTarget has decreased discount rate from 8.2% to 7.3%.

Shared on 11 Mar 25

Fair value Decreased 2.86%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget Fair Value

US$7.14

47.5% undervalued

Future estimation in

Growth p.a.

Growth p.a.

%

Decrease

Increase

Current revenue growth rate

10.84%

IT revenue growth rate

0.51%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

8.98%

Calculation

US$47.63m

Earnings '28

x

31.42x

PE Ratio '28

=

US$1.50b

Market Cap '28

US$1.50b

Market Cap '28

/

162.03m

No. shares '28

=

US$9.23

Share Price '28

US$9.23 Share Price '28

Discounted to 2025 @ 8.96% p.a.

=

US$7.14

Fair Value '25